Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Description of CRISPR-Cas9 development and its prospects in human papillomavirus-driven cancer treatment

21 Nov 2022

Abstract excerpt

Human papillomaviruses (HPVs) have been recognized as the etiologic agents of various cancers and are called HPV-driven cancers. Concerning HPV-mediated carcinogenic action, gene therapy can cure cancer at the molecular level by means of the correction of specific genes or sites. CRISPR-Cas9, as a novel genetic editing technique, can correct errors in the genome and change the gene expression and function in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Viral gastroenteritis research and epidemiology
Share to Virus-based gene therapy research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36479105
DOI: 10.3389/fimmu.2022.1037124

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Description of CRISPR-Cas9 development and its prospects in human papillomavirus-driven cancer treatmentPMID 36479105Read ↗

Adenoviral Vectors Armed with PAPILLOMAVIRUs Oncogene Specific CRISPR/Cas9 Kill Human-Papillomavirus-Induced Cervical Cancer CellsSemantic proximity Read ↗

Current Status of CRISPR/Cas9 Application in Clinical Cancer Research: Opportunities and ChallengesSemantic proximity Read ↗

CRISPR-Cas system: recent advancements in prompt diagnosis of high-risk HPV genotypes in cervical cancer.Semantic proximity Read ↗

Genome Editing Approaches with CRISPR/Cas9 for Cancer Treatment: Critical Appraisal of Preclinical and Clinical Utility, Challenges, and Future ResearchSemantic proximity Read ↗

Delivery of genome editing tools: A promising strategy for HPV-related cervical malignancy therapySemantic proximity Read ↗

Development and evaluation of a CRISPR/Cas12a-based diagnostic test for rapid detection and genotyping of HR-HPV in clinical specimensSemantic proximity Read ↗

CRISPR-Cas9 as a Potential Cancer Therapy Agent: An UpdateSemantic proximity Read ↗

Disruption of HPV16-E7 by CRISPR/Cas System Induces Apoptosis and Growth Inhibition in HPV16 Positive Human Cervical Cancer CellsSemantic proximity Read ↗

CRISPR/Cas9: an overview of recent developments and applications in cancer researchSemantic proximity Read ↗

Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction.Semantic proximity Read ↗

CRISPR/Cas9 in cancer: An attempt to the present trends and future prospects.Semantic proximity Read ↗

Prospects and challenges of CRISPR /Cas9 gene‐editing technology in cancer researchSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.